Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release
- 1 November 2004
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 156 (1-2) , 146-152
- https://doi.org/10.1016/j.jneuroim.2004.07.015
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Melatonin‐induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late‐phase activation of NF‐κB and AP‐1The FASEB Journal, 2003
- Tolerance, DCs and tryptophan: much ado about IDOTrends in Immunology, 2003
- Regulation of gene expression by oxygen: NF-κB and HIF-1, two extremesPublished by Elsevier ,2002
- N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidantThe FASEB Journal, 2001
- Myeloperoxidase-Catalyzed Oxidation of Melatonin by Activated NeutrophilsBiochemical and Biophysical Research Communications, 2000
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cellsJournal of Neuroimmunology, 1995
- Elastase and cathepsin G of human monocytes: heterogeneity and subcellular localization to peroxidase-positive granules.Journal of Histochemistry & Cytochemistry, 1990
- A novel neutrophil-activating factor produced by human mononuclear phagocytes.The Journal of Experimental Medicine, 1988
- N-acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesisBiochemical and Biophysical Research Communications, 1984